版本:
中国

BRIEF-Bellerophon therapeutics announces management transition

Sept 20 Bellerophon Therapeutics Announces Planned Management Transition by year end

* Jonathan Peacock will retain his position as chairman of board

* Fabian Tenenbaum, current chief financial officer and chief business officer, to be chief executive officer

* The transition will be completed by end of 2016 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐